FELI-CELL
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

FELI-CELL Trademark

Serial Number: 79282223 • Registration: 6331064

FELI-CELL is a trademark filed by Boehringer Ingelheim Veterinary Medicine Belgium, naamloze vennootschap on February 21, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Boehringer Ingelheim Veterinary Medicine Belgium, naamloze vennootschap (5 trademarks)

Noorwegenstraat 4

Entity Type: 78

GLOBAL STEM CELL TECHNOLOGY, afgekort G.S.T., naamloze vennootschap (2 trademarks)

Noorwegenstraat 4

Entity Type: 32

Trademark Details

Filing Date

February 21, 2020

Registration Date

April 27, 2021

Published for Opposition

February 9, 2021

Cancellation Date

March 10, 2023

Goods & Services

Veterinary preparations, namely, stem cells for veterinary purposes; surgical implants comprised of living tissues grown from stem cells, for animals; dietary supplements for animals; all of the foregoing goods for the treatment of chronic kidney disease, stomatitis, pain and inflammation

Filing History

CANCELLATION TERMINATED NO. 999999
Jun 6, 2023 CANT
CANCELLATION GRANTED NO. 999999
Jun 6, 2023 CANG
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Mar 28, 2023 DENC
DEATH OF INTERNATIONAL REGISTRATION
Mar 28, 2023 DETH
CANCELLATION INSTITUTED NO. 999999
Feb 27, 2023 PETC
CHANGE OF NAME/ADDRESS REC'D FROM IB
Dec 31, 2021 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 4, 2021 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Aug 11, 2021 XXSS
GENERIC MADRID TRANSACTION CREATED
Aug 11, 2021 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 27, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Apr 27, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 9, 2021 NPUB
PUBLISHED FOR OPPOSITION
Feb 9, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Feb 6, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 20, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 20, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 20, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 7, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 7, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 7, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 7, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 7, 2021 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 7, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 7, 2020 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Dec 7, 2020 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 4, 2020 GNFN
FINAL REFUSAL E-MAILED
Aug 4, 2020 GNFR
FINAL REFUSAL WRITTEN
Aug 4, 2020 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 20, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 20, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 20, 2020 TROA
REFUSAL PROCESSED BY IB
Jul 3, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 16, 2020 RFCS
REFUSAL PROCESSED BY MPU
Jun 16, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 15, 2020 RFCR
NON-FINAL ACTION WRITTEN
May 14, 2020 CNRT
ASSIGNED TO EXAMINER
May 11, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 7, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 3, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 2, 2020 REPR